TY - JOUR
KW - cocaine use disorder
KW - citalopram
KW - drop-the-loser
KW - Bayesian adaptive design
KW - Randomized Clinical Trial
KW - Empirical Study
KW - Quantitative Study
KW - Human
KW - Male
KW - Female
KW - Adulthood (18 yrs & older)
KW - Drug Therapy
KW - Substance use disorder
KW - Drug Abstinence
KW - cocaine
KW - Statistical Probability
KW - Serotonin reuptake inhibitors
KW - Randomized Clinical Trials
KW - article
KW - US
KW - 3383:Drug & Alcohol Rehabilitation
KW - Double-Blind Method
KW - Humans
KW - Bayes Theorem
KW - Adult
KW - Treatment Outcome
AU - Robert Suchting
AU - Charles E. Green
AU - Constanza de Dios
AU - Jessica Vincent
AU - F. G. Moeller
AU - Scott D. Lane
AU - Joy M. Schmitz
A1 - 
AD - Faillace Department of Psychiatry and Behavioral Sciences, UTHealth McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, US Robert.Suchting@uth.tmc.edu; Department of Pediatrics, Center for Clinical Research and Evidence-Based Medicine, UTHealth McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, US ; Virginia Commonwealth University, Richmond, VA, US ; Suchting, Robert,Robert.Suchting@uth.tmc.edu
BT - Drug and alcohol dependence
C5 - Opioids & Substance Use
DO - 10.1016/j.drugalcdep.2021.109054
JF - Drug and alcohol dependence
LA - English
M1 - Journal Article
PY - 2021
SN - 0376-8716, 0376-8716
SP - 7
T1 - Citalopram for treatment of cocaine use disorder: A Bayesian drop-the-loser randomized clinical trial
T2 - Drug and alcohol dependence
TI - Citalopram for treatment of cocaine use disorder: A Bayesian drop-the-loser randomized clinical trial
U1 - Opioids & Substance Use
U3 - 10.1016/j.drugalcdep.2021.109054
VL - 228
VO - 0376-8716, 0376-8716
Y1 - 2021
Y2 - Nov 01
ER -